Cost-Effectiveness of Pooled Nucleic Acid Amplification Testing for Acute HIV Infection after Third-Generation HIV Antibody Screening and Rapid Testing in the United States: A Comparison of Three Public Health Settings

• Angela B. Hutchinson ,

  * E-mail: ash2@cdc.gov

  Affiliation Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Pragna Patel,

  Affiliation Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Stephanie L. Sansom,

  Affiliation Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Paul G. Farnham,

  Affiliation Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Timothy J. Sullivan,

  Affiliation Wadsworth Center, New York State Department of Health, Albany, New York, United States of America

  ⨯
• Berry Bennett,

  Affiliation Retrovirology Section, Florida Bureau of Laboratories, Jacksonville, Florida, United States of America

  ⨯
• Peter R. Kerndt,

  Affiliation Sexually Transmitted Disease Program, Los Angeles Department of Health Services, Los Angeles, California, United States of America

  ⨯
• Robert K. Bolan,

  Affiliation LA Gay and Lesbian Center, Los Angeles, California, United States of America

  ⨯
• James D. Heffelfinger,

  Affiliation Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Vimalanand S. Prabhu,

  Affiliation Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Bernard M. Branson

  Affiliation Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯